The addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for advanced colorectal cancer: results of the MRC COIN trial.

Timothy S. Maughan, Richard A. Adams, Christopher G. Smith, Angela M. Meade, Matthew T. Seymour, Richard H. Wilson, Shelley Idziaszczyk, Rebecca Harris, David Fisher, Sarah L. Kenny, Edward Kay, Jenna K. Mitchell, Ayman Madi, Bharat Jasani, Michelle D. James, John Bridgewater, M. John Kennedy, Bart Claes, Diether Lambrechts, Richard KaplanJeremy P. Cheadle

Research output: Contribution to journalArticle

709 Citations (Scopus)

Fingerprint Dive into the research topics of 'The addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for advanced colorectal cancer: results of the MRC COIN trial.'. Together they form a unique fingerprint.

Medicine & Life Sciences